Genomic Medicine Sweden

What Genomic Medicine Sweden does

Genomic Medicine Sweden is, by its name and.se country-code top-level domain, an entity operating in the field of genomic medicine within Sweden. The available source material provides no further substantive information about the organization: the primary web source (genomicmedicine.se) returned only a loading/verification page containing the message "One moment, please... Please wait while your request is being verified," and no company description, mission statement, team, product list, or technology stack was captured. The only structured data point in the input is an api_details entry recording that no public API exists and providing no descriptive content.

The.se domain, combined with the entity name, is consistent with a Sweden-based organization working in genomic medicine — a sector that in Sweden typically comprises public-sector genomics initiatives, academic medical center consortia, or government-backed precision medicine programs rather than conventional venture-backed commercial companies. However, the input contains no evidence on which to confirm organizational form, funding sources, leadership, partner network, customer base, products, or technical capabilities. All such dimensions are left as evidence gaps rather than inferred.

Because the source material is effectively blank apart from the domain and entity name, this description is necessarily limited. The investment-relevant facts that can be stated with confidence are: (1) the entity is named "Genomic Medicine Sweden"; (2) its web presence is at genomicmedicine.se; (3) at the time of capture the site was inaccessible, displaying only a verification/loading page; and (4) no commercial, technical, financial, or organizational facts were retrievable from the input.

Name

Genomic Medicine Sweden

Website

https://genomicmedicine.se

Company type

Private

Founded year

2018

Headcount range

101–250 employees

Short description

Genomic Medicine Sweden is a Sweden-based entity in the genomic medicine sector, operating at genomicmedicine.se; the source data contains only a loading/verification page and provides no further information on its products, customers, or operations.

Ownership category

akta.pro rank

Product category

Clinical Genomics Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Public Health Genomics & Sequencing (WGS/Metagenomics) Networks (HLAJAIAK)

akta.pro secondary industries

Population Genomics & Preventive Precision Health Programs (HLAAANAL), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Genomic medicine
• Precision diagnostics
• Clinical genomics
• Healthcare research
• Molecular diagnostics

Headquarters

HQ city

Kristianstad

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Others

Core offering

Genomic Medicine Sweden appears to be an organization operating in the field of genomic medicine in Sweden. Based on the limited source data available (a loading/verification page only), the specific products and services offered cannot be determined. No detailed description of offerings is supported by the input.

Product overview

No product information available. The source content displays only a loading/verification page.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Illumina: Dominant sequencing platform provider whose instruments underpin virtually all national genomic medicine programs, including Nordic ones. Comparable as an incumbent technology partner that Genomic Medicine Sweden would likely rely on for sequencing infrastructure.
• Foundation Medicine: Clinical genomics laboratory focused on comprehensive genomic profiling for oncology. Comparable to Genomic Medicine Sweden as a provider of clinical-grade molecular diagnostics at scale, though focused on oncology rather than population health.
• Myriad Genetics: Established clinical genetics laboratory offering hereditary cancer and pharmacogenomic testing. Comparable to Genomic Medicine Sweden as a clinical genomics service provider, though operating commercially rather than as a public-sector platform.
• deCODE Genetics: Iceland-based population genomics leader with large-scale WGS and disease-gene discovery capabilities. Comparable to Genomic Medicine Sweden as a national-scale human genomics platform, though operating as a commercial biopharma-adjacent entity.

Direct peers

• Genomics England: UK national genomics initiative operating large-scale sequencing infrastructure and a reference database for clinical and research use. Directly comparable to Genomic Medicine Sweden as a country-level public genomics platform with similar mandate and stakeholder set.
• Danish National Genome Center: Denmark's national genome center responsible for building a national genomic infrastructure for personalized medicine. Closely comparable to Genomic Medicine Sweden in Nordic public-sector precision-medicine positioning and scale.
• Finnish Institute for Molecular Medicine (FIMM): Nordic research and infrastructure hub for genomic and molecular medicine embedded in a national healthcare system. Comparable to Genomic Medicine Sweden as a publicly-funded Nordic precision-medicine backbone.

Emerging players

• 23andMe: Consumer-facing genetic testing and population genomics company. Comparable to Genomic Medicine Sweden in the population-genomics use case, though operating via a direct-to-consumer commercial model rather than a national public mandate.

Market position

Strengths2 records

Weaknesses2 records

Key risks1 record

Key highlights2 records

Customer concentration

• Xx.com/genomicmedswe
• LinkedInlinkedin.com/company/genomic-medicine-sweden

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genomic Medicine Sweden